238 related articles for article (PubMed ID: 1710288)
1. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.
Longnecker R; Druker B; Roberts TM; Kieff E
J Virol; 1991 Jul; 65(7):3681-92. PubMed ID: 1710288
[TBL] [Abstract][Full Text] [Related]
2. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.
Burkhardt AL; Bolen JB; Kieff E; Longnecker R
J Virol; 1992 Aug; 66(8):5161-7. PubMed ID: 1321296
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2.
Longnecker R
Leukemia; 1994 Apr; 8 Suppl 1():S46-50. PubMed ID: 8152303
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
5. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.
Miller CL; Burkhardt AL; Lee JH; Stealey B; Longnecker R; Bolen JB; Kieff E
Immunity; 1995 Feb; 2(2):155-66. PubMed ID: 7895172
[TBL] [Abstract][Full Text] [Related]
6. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1.
Mosialos G; Hanissian SH; Jawahar S; Vara L; Kieff E; Chatila TA
J Virol; 1994 Mar; 68(3):1697-705. PubMed ID: 8107230
[TBL] [Abstract][Full Text] [Related]
7. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
Longnecker R; Kieff E
J Virol; 1990 May; 64(5):2319-26. PubMed ID: 2157888
[TBL] [Abstract][Full Text] [Related]
8. In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).
Rochford R; Miller CL; Cannon MJ; Izumi KM; Kieff E; Longnecker R
Arch Virol; 1997; 142(4):707-20. PubMed ID: 9170499
[TBL] [Abstract][Full Text] [Related]
9. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
Miller CL; Lee JH; Kieff E; Longnecker R
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Longnecker R
Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
Wang D; Liebowitz D; Wang F; Gregory C; Rickinson A; Larson R; Springer T; Kieff E
J Virol; 1988 Nov; 62(11):4173-84. PubMed ID: 2845129
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
13. 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.
Franken M; Annis B; Ali AN; Wang F
J Virol; 1995 Dec; 69(12):8011-9. PubMed ID: 7494314
[TBL] [Abstract][Full Text] [Related]
14. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.
Lee SP; Thomas WA; Blake NW; Rickinson AB
Eur J Immunol; 1996 Aug; 26(8):1875-83. PubMed ID: 8765034
[TBL] [Abstract][Full Text] [Related]
15. The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization.
Brielmeier M; Mautner J; Laux G; Hammerschmidt W
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2807-18. PubMed ID: 8922475
[TBL] [Abstract][Full Text] [Related]
16. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
Longnecker R; Miller CL; Miao XQ; Tomkinson B; Kieff E
J Virol; 1993 Apr; 67(4):2006-13. PubMed ID: 8383224
[TBL] [Abstract][Full Text] [Related]
17. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
18. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
19. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
Faris M; Gaskin F; Parsons JT; Fu SM
J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
[TBL] [Abstract][Full Text] [Related]
20. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.
Yue W; Gershburg E; Pagano JS
J Virol; 2005 May; 79(9):5880-5. PubMed ID: 15827205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
